professional documents
home
Upload
docsters
Upload

search results


Drug Development for Resistant Pathogens IDSA PhRma FDA Working Group Meeting

FDADocs 5/12/2008 | 0 (0) | 18 | 0 | 0 | English

Drug Development for Resistant Pathogens-PhRMA Antibiotics Working GroupFrancis P. Tally MD Cubist Pharmaceuticals, Inc. November 19, 2002Antimicrobial Resistance in Nosoc...  ... more>>

FDA experience and perspective on non inferiority trials Presentations

FDADocs 5/12/2008 | 0 (0) | 41 | 0 | 0 | English

FDA Experience and Perspective on Non-Inferiority TrialsRobert J. Temple, M.D. Associate Director for Medical Policy Center for Drug Evaluation and Research U.S. Food and Drug AdministrationFDA  ... more>>

Issues and Controversies in DILI Session I FDA January 24 25 2007

FDADocs 5/12/2008 | 0 (0) | 16 | 0 | 0 | English

Issues??and??Controversies??in??DILI?? Session??I:????FDA??Concept??Paper???????Premarketing...?? UNC?? GSK?? FDA?? FDA?? PhRMA??Session??1.1?? Drafting??of??Concept??Paper:????Premarketing  ... more>>

FDA Review of Investigational Cell Based Therapies Resource Tools Framework and Issues

FDADocs 5/12/2008 | 0 (0) | 20 | 0 | 0 | English

://www.fda.gov/cber/guidelines.htm. For questions on the content of this guidance, contact the  ... more>>

CALL FOR ABSTRACTS Poster Session on Genomics and FDA Science Forums

FDADocs 5/12/2008 | 0 (0) | 19 | 0 | 0 | English

CALL FOR ABSTRACTS Poster Session on Genomics and Proteomics10TH Annual FDA Science ForumFDA Science: The Critical Path from Concept to ConsumerMay 18-19, 2004, Washington Convention Center  ... more>>

FCG FDA SPL Demo Conference Meeting and Workshop Presentations by CDER Staff

FDADocs 5/12/2008 | 0 (0) | 27 | 1 | 0 | English

SPL DemonstrationJune 4, 2004Who is FCG?Who is FCG?A leading provider of consulting, technology, applied research and outsourcing services to the life sciences and he...  ... more>>

FDA Flawed Gate keeping Testimony Vera Sharav President Meeting Information

FDADocs 5/12/2008 | 0 (0) | 13 | 0 | 0 | English

FDA Flawed Gate keepingTestimony Vera Sharav President Alliance for Human Research Protection... intervention.???FDA Prozac Safety Review, 1990???The data showed higher percentages of suicidality  ... more>>

FDA Public Hearing Regarding Medication Guide Program Reform Meeting Information

FDADocs 5/12/2008 | 0 (0) | 23 | 0 | 0 | English

FDA Public Hearing Regarding Medication Guide Program ReformJune 12, 2007Steve Heidenthal, R.Ph. CVS Caremark Corporation-0-CVS Caremark BackgroundIntegrated pharmacy services  ... more>>

FDA s NPRM on Removing the Essential use Designations of Marketed Moieties Meeting information

FDADocs 5/12/2008 | 0 (0) | 13 | 0 | 0 | English

FDA???s NPRM on Removing the Essential-use Designations of 7 Marketed ???Moieties???Robert J... ozone depletion ??? Introduction to relevant decisions of the Montreal Protocol, U.S. Laws, and FDA  ... more>>

FDA Review of Rx to OTC Consumer Studies Involving Adolescents Meeting information

FDADocs 5/12/2008 | 0 (0) | 19 | 0 | 0 | English

FDA Review of Rx to OTC FDA Review of Rx to OTC Consumer Studies involving Consumer Studies... Nonprescription Clinical Evaluation, FDA Division of Nonprescription Clinical Evaluation, FDAAdolescent  ... more>>


   
  results / page   15/25/50 Page: 2 of 33 << prev 12345...33 next >>